Literature DB >> 6271049

Treatment of gonorrhea: comparison of cefotaxime and penicillin.

M L Simpson, M Y Khan, Y Siddiqui, R P Gruninger, D I Wigren.   

Abstract

Ninety-seven patients with 118 sites infected with Neisseria gonorrhoeae were treated with a single dose of either procaine penicillin G (4.8 x 10(6) U) or cefotoxime (1.0 g) intramuscularly. Only the penicillin group took 1 g of probenecid orally. The numbers of infected sites in each treatment group were as follows: penicillin-urethra, 37; rectum, 9; cervix, 8; and pharynx, 4; cefotaxime-urethra, 42; rectum, 9; cervix, 5; and pharynx, 4. The cure rates in each treatment group were 100%. No adverse reactions were noted in either group. beta-Lactamase-positive N. gonorrhoeae strains were not found. Ninety-five percent of clinical isolates were inhibited by less than or equal to 0.007 micrograms of cefotaxime and less than or equal to 0.25 micrograms of penicillin per ml. In this study cefotaxime was as effective as procaine penicillin in the treatment of uncomplicated gonorrhea.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271049      PMCID: PMC181525          DOI: 10.1128/AAC.19.5.798

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae.

Authors:  P R Murray; J L Christman; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

2.  Pharmacokinetics of cefotaxime.

Authors:  K P Fu; P Aswapokee; I Ho; C Matthijssen; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

3.  Penicillinase-producing Neisseria gonorrhoeae.

Authors:  C W Phillips; R D Aller; S N Cohen
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

4.  Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969.

Authors:  J E Martin; A Lester; E V Price; J D Schmale
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

5.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S W Berg; M E Kilpatrick; W O Harrison; J A McCutchan
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

7.  Treatment of uncomplicated gonococcal urethritis with cefoxitin: comparison with penicillin.

Authors:  M S Siegel; S E Thompson; P L Perine; S T Brown; G Reynolds; C Thornsberry
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb
  7 in total
  4 in total

Review 1.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

Review 3.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

4.  Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis.

Authors:  Jiaru Yang; Subhash Dhital; Thomas Naderer
Journal:  J Clin Med       Date:  2019-12-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.